71. The first trial of CIM331, a humanized antihuman interleukin‐31 receptor A antibody, in healthy volunteers and patients with atopic dermatitis to evaluate safety, tolerability and pharmacokinetics of a single dose in a randomized, double‐blind, placebo‐controlled study. (1st February 2016) Authors: Nemoto, O.; Furue, M.; Nakagawa, H.; Shiramoto, M.; Hanada, R.; Matsuki, S.; Imayama, S.; Kato, M.; Hasebe, I.; Taira, K.; Yamamoto, M.; Mihara, R.; Kabashima, K.; Ruzicka, T.; Hanifin, J.; Kumagai, Y. Journal: British journal of dermatology Issue: Volume 174:Number 2(2016) Page Start: 296 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
72. The first trial of CIM331, a humanized antihuman interleukin‐31 receptor A antibody, in healthy volunteers and patients with atopic dermatitis to evaluate safety, tolerability and pharmacokinetics of a single dose in a randomized, double‐blind, placebo‐controlled study3. (19th December 2015) Authors: Nemoto, O.; Furue, M.; Nakagawa, H.; Shiramoto, M.; Hanada, R.; Matsuki, S.; Imayama, S.; Kato, M.; Hasebe, I.; Taira, K.; Yamamoto, M.; Mihara, R.; Kabashima, K.; Ruzicka, T.; Hanifin, J.; Kumagai, Y. Journal: British journal of dermatology Issue: Volume 174:Number 2(2016) Page Start: 296 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
73. The novel SLCO2A1 heterozygous missense mutation p.E427K and nonsense mutation p.R603* in a female patient with pachydermoperiostosis with an atypical phenotype. (1st May 2014) Authors: Niizeki, H.; Shiohama, A.; Sasaki, T.; Seki, A.; Kabashima, K.; Otsuka, A.; Takeshita, M.; Hirakiyama, A.; Okuyama, T.; Tanese, K.; Ishiko, A.; Amagai, M.; Kudoh, J. Journal: British journal of dermatology Issue: Volume 170:Number 5(2014:May) Page Start: 1187 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
74. The novel SLCO2A1 heterozygous missense mutation p.E427K and nonsense mutation p.R603* in a female patient with pachydermoperiostosis with an atypical phenotype. (May 2014) Authors: Niizeki, H.; Shiohama, A.; Sasaki, T.; Seki, A.; Kabashima, K.; Otsuka, A.; Takeshita, M.; Hirakiyama, A.; Okuyama, T.; Tanese, K.; Ishiko, A.; Amagai, M.; Kudoh, J. Journal: British journal of dermatology Issue: Volume 170:Number 5(2014:May) Page Start: 1187 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
75. Three cases of facial erythema with dryness and pruritus in psoriasis patients during treatment with IL‐17 inhibitors. (24th October 2017) Authors: Oiwa, T.; Honda, T.; Otsuka, A.; Kabashima, K. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 32:Number 4(2018) Page Start: e122 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
76. Three‐dimensional evaluation of subclinical extension of extramammary Paget disease: visualization of the histological border and its comparison to the clinical border. (1st July 2017) Authors: Murata, T.; Honda, T.; Egawa, G.; Kitoh, A.; Dainichi, T.; Otsuka, A.; Nakajima, S.; Kore‐eda, S.; Kaku, Y.; Nakamizo, S.; Endo, Y.; Fujisawa, A.; Miyachi, Y.; Kabashima, K. Journal: British journal of dermatology Issue: Volume 177:Number 1(2017) Page Start: 229 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
77. Three‐dimensional evaluation of subclinical extension of extramammary Paget disease: visualization of the histological border and its comparison to the clinical border. (4th May 2017) Authors: Murata, T.; Honda, T.; Egawa, G.; Kitoh, A.; Dainichi, T.; Otsuka, A.; Nakajima, S.; Kore‐eda, S.; Kaku, Y.; Nakamizo, S.; Endo, Y.; Fujisawa, A.; Miyachi, Y.; Kabashima, K. Journal: British journal of dermatology Issue: Volume 177:Number 1(2017) Page Start: 229 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
78. Upregulation of granzyme B and interferon‐γ mRNA in responding lesions by treatment with nivolumab for metastatic melanoma: a case report. (2nd February 2016) Authors: Anegawa, H.; Otsuka, A.; Kaku, Y.; Nonomura, Y.; Fujisawa, A.; Endo, Y.; Kabashima, K. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 30:Number 12(2016:Dec.) Page Start: e231 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
79. Up‐dosing of nivolumab may induce serious immune‐related adverse events. (5th October 2021) Authors: Takamoto, K.; Komori, T.; Ishida, Y.; Kambe, N.; Kabashima, K. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 36:Number 2(2022) Page Start: e141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
80. What's in a name? Atopic dermatitis or atopic eczema, but not eczema alone. Issue 12 (30th June 2017) Authors: Silverberg, J. I.; Thyssen, J. P.; Paller, A. S.; Drucker, A. M.; Wollenberg, A.; Lee, K. H.; Kabashima, K.; Todd, G.; Schmid‐Grendelmeier, P.; Bieber, T. Journal: Allergy Issue: Volume 72:Issue 12(2017:Dec.) Page Start: 2026 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗